According to FutureWise analysis the market for antisense oligonucleotides in 2023 is US$ 2.12 billion, and is expected to reach US$ 4.73 billion by 2031 at a CAGR of 10.50%.
Antisense oligonucleotides, also called ASOs or AONs, are small molecules used to prevent or alter the production of proteins. These ASOs consist of short, single-stranded DNA fragments with complementary sequences to a specific mRNA. Proteins serve as the essential workforce within cells, overseeing various cellular processes. They are made in a two-step process: first, a specific gene responsible for encoding a particular protein is converted into a messenger RNA (mRNA), which serves as an instructional blueprint. This mRNA carries the genetic information from the gene to the cellular compartment responsible for protein synthesis. Within this compartment, the mRNA's instructions are translated into the corresponding protein. ASOs can also recruit cellular machinery that leads to the degradation of the targeted mRNA. This further prevents the production of the corresponding protein.
ASOs have various applications in treating various diseases, including ocular disease, cancer, diabetes, Amyotrophic Lateral Sclerosis (ALS), etc. ASOs have been analyzed as a potential treatment for certain ocular diseases. They can be developed to target specific genetic mutations associated with conditions like inherited retinal disorders or other ocular diseases. Also, cancer therapy targets specific genes or gene products involved in the growth or progression of cancer. Moreover, ASOs have been examined for their potential in treating diabetes, especially in cases where specific genetic factors contribute to the disease. They target genes associated with insulin production, insulin sensitivity, or other factors applicable to glucose metabolism.
FutureWise Market Research has published a report that provides an insightful analysis antisense oligonucleotides market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts antisense oligonucleotides market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.